Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis.

Ayele Semachew Kasa, Tadesse Dagget, Yeshiwork Beyene, Getnet Dessie, Aklilu Endalamaw, Yinager Workineh, Emiru Ayalew, Balew Zeleke, Sitotaw Kerie, Getasew Mulat, Worku Animaw
Author Information
  1. Ayele Semachew Kasa: Department of Adult Health Nursing, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia. finoteayu24@gmail.com. ORCID
  2. Tadesse Dagget: Department of Adult Health Nursing, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
  3. Yeshiwork Beyene: Department of Adult Health Nursing, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
  4. Getnet Dessie: Department of Adult Health Nursing, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
  5. Aklilu Endalamaw: Department of Pediatrics and Child Health Nursing, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
  6. Yinager Workineh: Department of Pediatrics and Child Health Nursing, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
  7. Emiru Ayalew: Department of Adult Health Nursing, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
  8. Balew Zeleke: Department of Pediatrics and Child Health Nursing, College of Medicine and Health Science, Bahir Dar University, Bahir Dar, Ethiopia.
  9. Sitotaw Kerie: Department of Adult Health Nursing, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
  10. Getasew Mulat: ALKAN Health Science Business and Technology College, Bahir Dar, Ethiopia.
  11. Worku Animaw: Department of Adult Health Nursing, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.

Abstract

BACKGROUND: Though cervical cancer is largely preventable, it is still the second most common female cancer globally and the leading cause of cancer deaths among females in African. Though many efforts have been done to study the burden of the disease in Ethiopia, primary studies examining the prevalence of precancerous cervical lesions are fragmented. Hence, this systematic review and meta-analysis is aimed at estimating the pooled prevalence of Precancerous cervical lesion and its trends in Ethiopia.
METHODS: This systematic review and meta-analysis was conducted using the following electronic databases. PubMed, Web of Science, SCOPUS, Science Direct, Google Scholar, African Index Medicus (AIM), African Journals Online databases, and Addis Ababa and Bahir Dar Universities research repositories were searched following the Preferred Items for Systematic Review and Meta-analysis (PRISMA) Guideline. STATA 15 statistical software was used to analyze the data. The quality of the included studies was assessed using the Joanna Briggs Institute (JBI) quality appraisal tool for meta-analysis. Heterogeneity between studies was assessed using the Cochrane Q test and I test statistics based on the random effects model. A random effects model was computed to estimate the pooled prevalence of Precancerous cervical lesion in Ethiopia. Finally, the trend of Precancerous cervical lesion in the country was presented.
RESULT: Seventeen studies with a total of 26,112 participants were included in the analysis. The pooled prevalence of Precancerous cervical lesion was 15.16 (95% CI 10.16-19.70). The subgroup analysis by region showed the highest prevalence of Precancerous cervical lesion at the Southern Nations and Nationalities Peoples Region (19.65%; 95% CI 15.51-23.80). The trend of Precancerous cervical lesion prevalence showed an increased pattern over time.
CONCLUSION: Approximately one among six of the study participants had Precancerous cervical lesion. The trend also showed that there is still an increasing Precancerous cervical lesion in Ethiopia. Best practices in achieving high vaccination coverage shall be informed by practices in other successful countries.

Keywords

References

  1. Obstet Gynecol. 2008 Jun;111(6):1380-7 [PMID: 18515522]
  2. Psychol Methods. 2006 Jun;11(2):193-206 [PMID: 16784338]
  3. Glob Health Sci Pract. 2016 Mar 25;4(1):87-98 [PMID: 27016546]
  4. BMC Res Notes. 2015 Oct 29;8:618 [PMID: 26515769]
  5. J Womens Health (Larchmt). 2008 Mar;17(2):279-85 [PMID: 18321179]
  6. Infect Agent Cancer. 2014 Oct 08;9(1):33 [PMID: 25320636]
  7. BMJ. 2003 Sep 6;327(7414):557-60 [PMID: 12958120]
  8. PLoS One. 2013 Dec 20;8(12):e84519 [PMID: 24376818]
  9. Int J Health Sci (Qassim). 2016 Jan;10(1):137-43 [PMID: 27004064]
  10. BMC Infect Dis. 2018 Jun 22;18(1):283 [PMID: 29929480]
  11. Int J Womens Health. 2012;4:55-60 [PMID: 22393304]
  12. Cancer. 2012 Sep 15;118(18):4372-84 [PMID: 22252462]
  13. PLoS Med. 2009 Jul 21;6(7):e1000097 [PMID: 19621072]
  14. Int J Gynaecol Obstet. 2009 Nov;107(2):99-102 [PMID: 19619874]
  15. PLoS One. 2016 Mar 10;11(3):e0149908 [PMID: 26963098]
  16. Trop Med Int Health. 2009 Oct;14(10):1287-302 [PMID: 19772550]
  17. BMC Cancer. 2013 Jan 02;13:2 [PMID: 23282173]
  18. BMC Clin Pathol. 2015 Sep 23;15:16 [PMID: 26401120]
  19. Afr Health Sci. 2018 Sep;18(3):623-636 [PMID: 30602995]
  20. PLoS One. 2018 Jan 19;13(1):e0191506 [PMID: 29352278]
  21. West Afr J Med. 2007 Apr-Jun;26(2):143-7 [PMID: 17939318]
  22. BMC Womens Health. 2011 Oct 18;11:45 [PMID: 22008186]
  23. Ann Afr Med. 2010 Jul-Sep;9(3):194 [PMID: 20710114]
  24. Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S201-2 [PMID: 16419208]
  25. Cytopathology. 1992;3(3):139-48 [PMID: 1511118]
  26. Lancet. 2011 Oct 22;378(9801):1461-84 [PMID: 21924486]
  27. Int J Cancer. 2010 Dec 15;127(12):2893-917 [PMID: 21351269]
  28. Res Synth Methods. 2010 Apr;1(2):97-111 [PMID: 26061376]
  29. Indian J Community Med. 2010 Jan;35(1):86-8 [PMID: 20606928]
  30. Int J Health Sci (Qassim). 2019 May-Jun;13(3):4-9 [PMID: 31123433]
  31. Gynecol Oncol Rep. 2019 May 21;29:40-47 [PMID: 31309135]
  32. Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1434-8 [PMID: 22806169]
  33. Afr Health Sci. 2019 Mar;19(1):1695-1704 [PMID: 31149000]
  34. Bull World Health Organ. 2008 Jun;86(6):488-90 [PMID: 18568279]
  35. Ethiop Med J. 2015 Apr;53(2):65-74 [PMID: 26591294]
  36. J Obstet Gynaecol. 2011 Nov;31(8):759-62 [PMID: 22085071]
  37. Tuberculosis (Edinb). 2016 Jan;96:131-40 [PMID: 26631832]
  38. Niger J Clin Pract. 2012 Jul-Sep;15(3):326-32 [PMID: 22960970]
  39. Int J Epidemiol. 1996 Jun;25(3):488-93 [PMID: 8671548]
  40. J Prev Med Hyg. 2012 Dec;53(4):213-9 [PMID: 23469591]
  41. Tanzan J Health Res. 2009 Oct;11(4):163-9 [PMID: 20734694]
  42. Eur J Epidemiol. 2006;21(9):727-9 [PMID: 17072541]
  43. World J Methodol. 2012 Aug 26;2(4):27-32 [PMID: 25237614]

MeSH Term

Ethiopia
Female
Humans
Precancerous Conditions
Prevalence
Uterine Cervical Neoplasms
Vaccination Coverage

Word Cloud

Created with Highcharts 10.0.0cervicallesionprecancerousprevalenceEthiopiacancerstudiesreviewmeta-analysisAfricansystematicpooledusing15trendshowedThoughstillamongstudyfollowingdatabasesScienceSystematicqualityincludedassessedtestrandomeffectsmodelparticipantsanalysis95%CIpracticesPrecancerousCervicalBACKGROUND:largelypreventablesecondcommonfemalegloballyleadingcausedeathsfemalesmanyeffortsdoneburdendiseaseprimaryexamininglesionsfragmentedHenceaimedestimatingtrendsMETHODS:conductedelectronicPubMedWebSCOPUSDirectGoogleScholarIndexMedicusAIMJournalsOnlineAddisAbabaBahirDarUniversitiesresearchrepositoriessearchedPreferredItemsReviewMeta-analysisPRISMAGuidelineSTATAstatisticalsoftwareusedanalyzedataJoannaBriggsInstituteJBIappraisaltoolHeterogeneityCochraneQstatisticsbasedcomputedestimateFinallycountrypresentedRESULT:Seventeentotal26112161016-1970subgroupregionhighestSouthernNationsNationalitiesPeoplesRegion1965%51-2380increasedpatterntimeCONCLUSION:ApproximatelyonesixalsoincreasingBestachievinghighvaccinationcoverageshallinformedsuccessfulcountriesEthiopia:

Similar Articles

Cited By